Is it time to measure apolipoprotein B?

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Arteriosclerosis

• Publication date

  1990-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.ATV.10.5.665PMID 2206112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trade-offs on cutpoints for the treatment of hyperlipidemia

  1990cited by this paper
• Apoprotein measurements and their clinical application.

  1989cited by this paper
• Apolipoprotein B and apolipoprotein AI as predictors of coronary artery disease.

  1988cited by this paper
• Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.

  1986cited by this paper
• Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction.

  1986cited by this paper
• Apoproteins B and A-I and coronary artery disease in humans.

  1984cited by this paper
• The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.

  1984cited by this paper
• Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.

  1983cited by this paper
• Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis.

  1982cited by this paper

• Prognostic Value of Serum Lipoprotein (a) and Apo lipoprotein-B in diabetics with Myocardial Infarction and Chronic limb Threatening ischemia

  2020cites this paper
• Measuring and Knowing The Trouble With Cholesterol and Decision Making

  2017cites this paper
• Dietary guidelines for saturated fatty acids are not supported by the evidence

  2016cites this paper
• Beneficial effect of flaxseed oil on lipid metabolism in high cholesterol diet fed rats

  2015cites this paper
• Biochemical alterations in erythrocytes membrane lipid in experimentally induced atherosclerosis and their modulation with chitosan in rats

  2015cites this paper
• Hypolipidemic effect of curcumin in hyper-cholesterolemic rats

  2015cites this paper
• Non-high density lipoprotein-cholesterol and apolipoprotein B concentration in type 2 diabetes mellitus patients

  2013cites this paper
• Lipids, Lipoproteins, Apolipoproteins, and Other Cardiovascular Risk Factors

  2012cites this paper
• IS CARDIOVASCULAR RISK MORE IN DIABETICS BECAUSE OF LOWER APOLIPOPROTEIN A1 LEVELS RATHER THAN HIGHER APO B /APOA1 RATIO?

  2011cites this paper
• Capítulo 4 Subclases de lipoproteínas y concentración de partículas y riesgo de enfermedad cardiovascular

  2010cites this paper
• Has the association between saturated fatty acids, serum cholesterol and coronary heart disease been over emphasized?

  2009cites this paper
• Emerging Biomarkers for Primary Prevention of Cardiovascular Disease and Stroke

  2009influential citation
• Study of plasma levels of ApoA-I and ApoB for prognosis of acute ischemic stroke

  2009cites this paper
• Modulation of hypercholesterolemia-induced alterations in apolipoprotein B and HMG-CoA reductase expression by selenium supplementation.

  2006cites this paper
• Lipids in Health and Disease

  2005cites this paper
• Non-HDL cholesterol: into the spotlight.

  2003cites this paper
• Do spinal cord injuries adversely affect serum lipoprotein profiles?

  2003cites this paper
• Measurement of cholesterol and other lipoprotein constituents in the clinical laboratory.

  2000cites this paper
• Measurement of cholesterol and other lipoprotein constituents in the clinical laboratory.

  2000cites this paper
• The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.

  1999cites this paper
• Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group.

  1999cites this paper
• Comparison of Bezafibrate and Simvastatin in the Treatment of Dyslipidaemia in Patients with NIDDM

  1997cites this paper
• 12. Epidemiology and risk factors of coronary artery disease

  1996cites this paper
• Albuminuria, Insulin Resistance and Dyslipidaemia in Chinese Patients with Non‐insulin‐dependent Diabetes (NIDDM)

  1996cites this paper
• Apolipoprotein B levels and related factors in a rural white South African community--the CORIS study. Coronary Risk Factor Study.

  1996cites this paper
• Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins.

  1996cites this paper
• Epidemiology and risk factors of coronary artery disease

  1996cites this paper
• Genetic basis of lipoprotein disorders.

  1995cites this paper
• International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of International Reference Material.

  1994cites this paper
• Quantitation of Plasma Apolipoproteins in the Primary and Secondary Prevention of Coronary Artery Disease

  1994cites this paper
• Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production.

  1994cites this paper
• Central Adiposity and Atherogenic Lipids in Saudi Diabetics

  1994cites this paper
• Coronary artery disease risk factors from a genetic and developmental perspective.

  1994cites this paper
• The Effects of Enalapril and Nifedipine on Carbohydrate and Lipid Metabolism in NIDDM

  1994cites this paper
• Relationship of blood cholesterol and apoprotein B levels to angiographically defined coronary artery disease in young males

  1993cites this paper
• Apoproteins, lipoprotein subfractions, and the risk of coronary artery disease.

  1993cites this paper
• Lipids, lipoproteins and other coronary risk factors in Chinese male survivors of myocardial infarction.

  1993cites this paper
• Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study.

  1993cites this paper
• Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents.

  1993cites this paper
• Effect of a single oat bran cereal breakfast on serum cholesterol, lipoproteins, and apolipoproteins in patients with hyperlipoproteinemia type IIa.

  1992cites this paper
• Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females

  1992cites this paper
• Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.

  1992cites this paper
• Cholesterol lowering as a treatment for established coronary heart disease.

  1992cites this paper
• Fasting plasma lipid measurements following cisplatin chemotherapy in patients with germ cell tumors.

  1992cites this paper
• A fresh look at the atherogenic remnant hypothesis.

  1992cites this paper
• Hypertriglyceridemia: Examining its role in coronary heart disease

  1991cites this paper
• Genetic structure and the search for genotype-phenotype relationships: an example from disequilibrium in the Apo B gene region.

  1991cites this paper
• What should be done about asymptomatic hypercholesterolaemia?

  1991cites this paper
• Measuring and knowing. The trouble with cholesterol and decision making.

  1991cites this paper
• Standardization of apolipoprotein measurements

  1991cites this paper
• Effect of plasma triglyceride concentrations on the accuracy of immunoturbidimetric assays of apolipoprotein B.

  1991cites this paper
• Cholesterol screening in childhood.

  1991cites this paper
• Apolipoproteins and risk of coronary heart disease.

  1991cites this paper
• [Cholesterol and triglycerides in atherosclerosis: epidemiologic and physiopathologic considerations].

  1991cites this paper
• Does measurement of apolipoprotein B have a place in cholesterol management?

  1990cites this paper
• Genetic basis of lipoprotein disorders.

  1989cites this paper
• Vascular Health and Risk Management Dovepress Combination of Niacin Extended-release and Simvastatin Results in a Less Atherogenic Lipid Profile than Atorvastatin Monotherapy

  year unknowncites this paper